Article

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medications

2022-04-29

Abstract excerpt

<h4>Background: </h4> High drug prices can limit treatment access. Patented drugs can be sold for prices far higher than the costs of production. This analysis aimed to determine prices currently feasible to treat COVID-19, HIV, and Hepatitis B or C, with WHO/FDA/NICE approved oral medications assuming competitive generic manufacture. Methods Data on Active Pharmaceutical Ingredients (API) exported from India wer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5f1ac57e-2a90-57eb-ab10-5df4aba2e808
DOI: 10.21203/rs.3.rs-1606136/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsDOI 10.21203/rs.3.rs-1606136/v1Read

Prices versus costs of production for molnupiravir as a COVID-19 treatmentSemantic proximity Read

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity Read

Differences in the cost of manufacturing pharmaceuticals in India for differently regulated markets: A comparative analysisSemantic proximity Read

Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesitySemantic proximity Read

The direct-medical costs associated with interferon-based treatment for Hepatitis C in VietnamSemantic proximity Read

Drug Pricing Evolution in Hepatitis C.Semantic proximity Read

Are quality medicines affordable? Evidence from a large survey of medicine price and quality in IndonesiaSemantic proximity Read

Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity Read

Current prices versus minimum costs of production for CFTR modulatorsSemantic proximity Read

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity Read

Impact of Generic Antiretroviral Drugs Introduction on Pharmaceutical Expenditure Patterns in the Netherlands: A Six-Year Retrospective Database Analysis from 2016 to 2022Semantic proximity Read

Shining a light in the black box of orphan drug pricingSemantic proximity Read